8-K: BiomX Sets 2025 Annual Meeting for October, Announces Shareholder Proposal Deadline
Shareholder Meeting Update
BiomX Inc. has announced the date for its 2025 Annual Meeting of Stockholders as October 16, 2025, and set the deadline for shareholder proposals for inclusion in its proxy statement.
Summary
- BiomX Inc. expects to hold its 2025 Annual Meeting of Stockholders on Thursday, October 16, 2025.
- The record date for the Annual Meeting has been fixed as the closing of business on August 22, 2025.
- The date of the 2025 Annual Meeting has been changed by more than 30 days from the anniversary date of the 2024 Annual Meeting of Stockholders.
- The deadline for receipt of stockholder proposals for inclusion in the company's proxy statement, pursuant to Rule 14a-8, is no later than 5:00 p.m., Eastern Time, on August 15, 2025.
- Stockholder proposals must comply with all applicable requirements of the SEC rules and regulations, including Rule 14a-8 under the Exchange Act and the company's Bylaws.
Sentiment
Score: 5
Explanation: The filing is purely procedural, announcing the date of the annual meeting and related deadlines. It contains no information that would typically be interpreted as positive or negative for the company's operations or financial health, thus indicating a neutral sentiment.
Future Outlook
The filing primarily provides procedural information regarding the upcoming 2025 Annual Meeting of Stockholders, including its date, record date, and the deadline for shareholder proposals. It does not contain forward-looking statements related to business operations, financial performance, or strategic guidance beyond these administrative details.
Management Comments
- Jonathan Solomon, Chief Executive Officer, signed the report on behalf of BiomX Inc.
Industry Context
This announcement is a routine corporate governance update common across publicly traded companies, ensuring compliance with SEC regulations regarding shareholder meetings and proposal submissions. It reflects standard practices for maintaining transparency and shareholder engagement.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Annual Meeting Scheduling | The 2025 Annual Meeting of Stockholders is scheduled for October 16, 2025, a change of more than 30 days from the anniversary date of the 2024 meeting. | 2025-10-16 | Ensures timely conduct of shareholder meeting and election of directors, aligning with corporate governance best practices. |
| Shareholder Proposal Deadline | A deadline of August 15, 2025, has been set for stockholder proposals to be included in the proxy statement, in accordance with Rule 14a-8 and company bylaws. | 2025-08-15 | Provides clarity and a defined timeline for shareholders to exercise their right to submit proposals for consideration at the annual meeting. |
Stakeholder Impact
- Shareholders: Informed of the date for the annual meeting, the record date for voting, and the deadline for submitting proposals for inclusion in the proxy statement.
Next Steps
- The company will hold its 2025 Annual Meeting of Stockholders on October 16, 2025.
- Stockholders wishing to submit proposals for inclusion in the proxy statement must do so by August 15, 2025.
Key Dates
| Date | Description |
|---|---|
| 2025-07-30 | Date of the current report filing. |
| 2025-08-15 | Deadline for receipt of stockholder proposals for inclusion in the proxy statement (5:00 p.m., Eastern Time). |
| 2025-08-22 | Record date for the 2025 Annual Meeting of Stockholders (closing of business). |
| 2025-10-16 | Expected date of the 2025 Annual Meeting of Stockholders. |
Keywords
BiomX Inc., Annual Meeting, Shareholder Proposals, Proxy Statement, Corporate Governance, SEC Filing, 8-K, Stockholders
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.